Study: Higher THC levels do not increase schizophrenia rates
Cannabis use has often been accused of triggering schizophrenia. But despite increased THC levels, the number of detected schizophrenia cases is not increasing. Why?
Most cannabis consumers have no problems with their use. A small portion, however, suffers from psychotic symptoms such as paranoia or schizophrenia.
Although several studies suggest that cannabis users are at higher risk of developing schizophrenia, one point remains largely disputed. Since the 1960s, rates of cannabis prevalence and potency have increased, but schizophrenia rates have not.
A recent study, published in the journal Psychological Medicine, can explain that.
1231 cannabis consumers were interviewed about their consumption experience, and a «pleasure score» and «psychotic experience score» were calculated. Based on these scores, they were asked whether they would continue to consume cannabis or if they thought they would stop in the future.
Those who reported the most enjoyment have no intention of stopping. Those, on the other hand, who had unpleasant experiences have either already stopped or are considering doing so in the future. The conclusion is that consumers' experiences with cannabis condition their consumption, regardless of age, sex, mental health history, or other drugs used.
This also suggests that the people at risk are also the ones who quit. Other experiences suggest that schizophrenic individuals have more psychotic episodes when they consume cannabis than non-schizophrenic individuals. And they compensate for their risk of developing schizophrenia by no longer consuming cannabis.
As the author of the study, Musa Sami, points out, these conclusions are only hypotheses that could explain this persistence. around 11:00 a.m. schizophrenia despite the increase in cannabis use. He also highlights the need to focus on the small portion of consumers who continue to use cannabis despite their history or psychotic alerts, even if some consumers who are likely to develop schizophrenia stop.
Via The Conversation
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Business2 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login